Endocytic mechanisms for targeted drug delivery

Advanced Drug Delivery Reviews

Volumn 59, Issue 8, 2007, Pages 748-758

  Bareford, Lisa M ^a   Swaan, Peter W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Clathrin; Endosomes; HPMA; Lysosomes; Receptor mediated endocytosis; Riboflavin

Indexed keywords

CLATHRINS; ENDOSOMES; LYSOSOMES; RECEPTOR MEDIATED ENDOCYTOSIS; RIBOFLAVIN;

CELLS; DISEASES; LIGANDS; MACROMOLECULES; MEDICAL NANOTECHNOLOGY; TUMORS;

DRUG DELIVERY;

ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; BOVINE SERUM ALBUMIN; CATHEPSIN B; CAVEOLIN; CHITOSAN; CHOLERA TOXIN B SUBUNIT; CLATHRIN; DEXTRAN; DOXORUBICIN; FOLIC ACID; GLUCOSYLCERAMIDASE; HORSERADISH PEROXIDASE; HUMAN SERUM ALBUMIN; HYDROXYPROPYL METHACRYLAMIDE; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LIPOSOME; LOW DENSITY LIPOPROTEIN; MACROGOL; MANNOSE 6 PHOSPHATE; MEMBRANE RECEPTOR; NANOCARRIER; NANOPARTICLE; NICOTINIC ACID; POLYLYSINE; POLYMER; RIBOFLAVIN; SUPEROXIDE DISMUTASE; TRANSFERRIN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ALZHEIMER DISEASE; BINDING AFFINITY; BIODEGRADATION; BIOENGINEERING; CANCER; CELL MIGRATION; CELL ORGANELLE; COMPLEX FORMATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; ENDOCYTOSIS; ENZYME RELEASE; GAUCHER DISEASE; HUMAN; INTRACELLULAR SPACE; LYSOSOME; LYSOSOME STORAGE DISEASE; MACROMOLECULE; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSPORT VESICLE;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOSOMES; HUMANS; LIGANDS; LYSOSOMAL STORAGE DISEASES; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; LYSOSOMES; MACROMOLECULAR SUBSTANCES; NANOMEDICINE; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; TRANSPORT VESICLES; VESICULAR TRANSPORT PROTEINS;

EID: 34548267667     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.06.008     Document Type: Review

References (72)

1. Juliano R.L., Astriab-Fisher A., and Falke D. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era. Mol. Interv. 1 (2001) 40-53
2. Castino R., Demoz M., and Isidoro C. Destination 'lysosome': a target organelle for tumour cell killing?. J. Mol. Recognit. 16 (2003) 337-348
3. Tate B.A., and Mathews P.M. Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment. Sci. Aging Knowl. Environ. 2006 (2006) re2
4. Sly W.S., and Vogler C. Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood-brain barrier. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5760-5762
5. Lu Y., and Low P.S. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54 (2002) 675-693
6. Wong H.L., Bendayan R., Rauth A.M., Xue H.Y., Babakhanian K., and Wu X.Y. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J. Pharmacol. Exp. Ther. 317 (2006) 1372-1381
7. Steinman R.M., Mellman I.S., Muller W.A., and Cohn Z.A. Endocytosis and the recycling of plasma membrane. J. Cell Biol. 96 (1983) 1-27
8. Qaddoumi M.G., Gukasyan H.J., Davda J., Labhasetwar V., Kim K.J., and Lee V.H. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol. Vis. 9 (2003) 559-568
9. D'Souza V.M., Bareford L.M., Ray A., and Swaan P.W. Cytoskeletal scaffolds regulate riboflavin endocytosis and recycling in placental trophoblasts. J. Nutr. Biochem. 17 (2006) 821-829
10. Rudenko G., Henry L., Henderson K., Ichtchenko K., Brown M.S., Goldstein J.L., and Deisenhofer J. Structure of the LDL receptor extracellular domain at endosomal pH. Science 298 (2002) 2353-2358
11. Diebold S.S., Plank C., Cotten M., Wagner E., and Zenke M. Mannose receptor-mediated gene delivery into antigen presenting dendritic cells. Somat. Cell Mol. Genet. 27 (2002) 65-74
12. Biessen E.A., Vietsch H., Rump E.T., Fluiter K., Kuiper J., Bijsterbosch M.K., and van Berkel T.J. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biochem. J. 340 Pt 3 (1999) 783-792
13. Mamot C., Drummond D.C., Greiser U., Hong K., Kirpotin D.B., Marks J.D., and Park J.W. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 63 (2003) 3154-3161
14. Biragyn A., Ruffini P.A., Coscia M., Harvey L.K., Neelapu S.S., Baskar S., Wang J.M., and Kwak L.W. Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo. Blood 104 (2004) 1961-1969
15. Foraker A.B., Khantwal C.M., and Swaan P.W. Current perspectives on the cellular uptake and trafficking of riboflavin. Adv. Drug Deliv. Rev. 55 (2003) 1467-1483
16. Mishra V., Mahor S., Rawat A., Gupta P.N., Dubey P., Khatri K., and Vyas S.P. Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J. Drug Target. 14 (2006) 45-53
17. Qian Z.M., Li H., Sun H., and Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54 (2002) 561-587
18. Rao P.N., Levine E., Myers M.O., Prakash V., Watson J., Stolier A., Kopicko J.J., Kissinger P., Raj S.G., and Raj M.H. Elevation of serum riboflavin carrier protein in breast cancer. Cancer Epidemiol. Biomark. Prev. 8 (1999) 985-990
19. Dunehoo A.L., Anderson M., Majumdar S., Kobayashi N., Berkland C., and Siahaan T.J. Cell adhesion molecules for targeted drug delivery. J. Pharm. Sci. 95 (2006) 1856-1872
20. Muro S., Schuchman E.H., and Muzykantov V.R. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. Molec. Ther. 13 (2006) 135-141
21. Muro S., Gajewski C., Koval M., and Muzykantov V.R. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood 105 (2005) 650-658
22. Stromhaug P.E., Berg T.O., Gjoen T., and Seglen P.O. Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes. Eur. J. Cell Biol. 73 (1997) 28-39
23. Mitra A., Nan A., Ghandehari H., McNeill E., Mulholland J., and Line B.R. Technetium-99m-labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution. Pharm. Res. 21 (2004) 1153-1159
24. Persiani S., and Shen W.C. Increase of poly(l-lysine) uptake but not fluid phase endocytosis in neuraminidase pretreated Madin-Darby canine kidney (MDCK) cells. Life Sci. 45 (1989) 2605-2610
25. Fujita T., Nishikawa M., Tamaki C., Takakura Y., Hashida M., and Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. J. Pharmacol. Exp. Ther. 263 (1992) 971-978
26. Wardman P. Indole-3-acetic acids and horseradish peroxidase: a new prodrug/enzyme combination for targeted cancer therapy. Curr. Pharm. Des. 8 (2002) 1363-1374
27. Renau-Piqueras J., Miragall F., and Cervera J. Endocytosis of cationized ferritin in human peripheral blood by resting T-lymphocytes. Cell Tissue Res. 240 (1985) 743-746
28. Huang S.N., and Swaan P.W. Involvement of a receptor-mediated component in cellular translocation of riboflavin. J. Pharmacol. Exp. Ther. 294 (2000) 117-125
29. Lamaze C., Dujeancourt A., Baba T., Lo C.G., Benmerah A., and Dautry-Varsat A. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7 (2001) 661-671
30. Pelkmans L., Kartenbeck J., and Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3 (2001) 473-483
31. Pelkmans L., and Helenius A. Endocytosis via caveolae. Traffic 3 (2002) 311-320
32. Chang W.J., Rothberg K.G., Kamen B.A., and Anderson R.G. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Biol. 118 (1992) 63-69
33. Dauty E., Remy J.S., Zuber G., and Behr J.P. Intracellular delivery of nanometric DNA particles via the folate receptor. Bioconjug. Chem. 13 (2002) 831-839
34. Schnitzer J.E. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv. Drug Deliv. Rev. 49 (2001) 265-280
35. Murthy N., Campbell J., Fausto N., Hoffman A.S., and Stayton P.S. Design and synthesis of pH-responsive polymeric carriers that target uptake and enhance the intracellular delivery of oligonucleotides. J. Control. Release 89 (2003) 365-374
36. Bathori G., Cervenak L., and Karadi I. Caveolae-an alternative endocytotic pathway for targeted drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 21 (2004) 67-95
37. Nichols B.J., and Lippincott-Schwartz J. Endocytosis without clathrin coats. Trends Cell Biol. 11 (2001) 406-412
38. Nichols B.J. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4 (2002) 374-378
39. Orlandi P.A., and Fishman P.H. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 141 (1998) 905-915
40. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
41. Harokopakis E., Childers N.K., Michalek S.M., Zhang S.S., and Tomasi M. Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens. J. Immunol. Methods 185 (1995) 31-42
42. Kudo M., Bao M., D'Souza A., Ying F., Pan H., Roe B.A., and Canfield W.M. The alpha- and beta-subunits of the human UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase [corrected] are encoded by a single cDNA. J. Biol. Chem. 280 (2005) 36141-36149
43. Kiselyov K., Jennigs Jr. J.J., Rbaibi Y., and Chu C.T. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 3 (2007)
44. Vogler C., Levy B., Grubb J.H., Galvin N., Tan Y., Kakkis E., Pavloff N., and Sly W.S. Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14777-14782
45. D'Souza V.M., Foraker A.B., Free R.B., Ray A., Shapiro P.S., and Swaan P.W. cAMP-coupled riboflavin trafficking in placental trophoblasts: a dynamic and ordered process. Biochemistry 45 (2006) 6095-6104
46. Hanover J.A., Beguinot L., Willingham M.C., and Pastan I.H. Transit of receptors for epidermal growth factor and transferrin through clathrin-coated pits. Analysis of the kinetics of receptor entry. J. Biol. Chem. 260 (1985) 15938-15945
47. Beyreuther K., and Masters C.L. Alzheimer's disease. The ins and outs of amyloid-beta. Nature 389 (1997) 677-678
48. Nixon R.A., Cataldo A.M., and Mathews P.M. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem. Res. 25 (2000) 1161-1172
49. Lad S.P., Neet K.E., and Mufson E.J. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 315-334
50. Castino R., Pace D., Demoz M., Gargiulo M., Ariatta C., Raiteri E., and Isidoro C. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. Int. J. Cancer 97 (2002) 775-779
51. Jacks T., and Weinberg R.A. Taking the study of cancer cell survival to a new dimension. Cell 111 (2002) 923-925
52. Selbo P.K., Hogset A., Prasmickaite L., and Berg K. Photochemical internalisation: a novel drug delivery system. Tumour Biol. 23 (2002) 103-112
53. Hruby M., Konak C., and Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release 103 (2005) 137-148
54. Prasmickaite L., Hogset A., Selbo P.K., Engesaeter B.O., Hellum M., and Berg K. Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy. Br. J. Cancer 86 (2002) 652-657
55. Lim C.J., and Shen W.C. Transferrin-oligomers as potential carriers in anticancer drug delivery. Pharm. Res. 21 (2004) 1985-1992
56. Wagner E., Zenke M., Cotten M., Beug H., and Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3410-3414
57. Wu D., Song B.W., Vinters H.V., and Pardridge W.M. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system. J. Drug Target. 10 (2002) 239-245
58. Sato Y., and Beutler E. Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages. J. Clin. Invest. 91 (1993) 1909-1917
59. Krinick N.L., Sun Y., Joyner D., Spikes J.D., Straight R.C., and Kopecek J. A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J. Biomater. Sci., Polym. Ed. 5 (1994) 303-324
60. Saikawa Y., Knight C.B., Saikawa T., Page S.T., Chabner B.A., and Elwood P.C. Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells. J. Biol. Chem. 268 (1993) 5293-5301
61. Paulos C.M., Reddy J.A., Leamon C.P., Turk M.J., and Low P.S. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Mol. Pharmacol. 66 (2004) 1406-1414
62. Theti D.S., Bavetsias V., Skelton L.A., Titley J., Gibbs D., Jansen G., and Jackman A.L. Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor. Cancer Res. 63 (2003) 3612-3618
63. Schneider R., Schmitt F., Frochot C., Fort Y., Lourette N., Guillemin F., Muller J.F., and Barberi-Heyob M. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorg. Med. Chem. 13 (2005) 2799-2808
64. Zheng G., Chen J., Li H., and Glickson J.D. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17757-17762
65. Harokopakis E., Hajishengallis G., and Michalek S.M. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. Infect. Immun. 66 (1998) 4299-4304
66. Greupink R., Bakker H.I., Reker-Smit C., van Loenen-Weemaes A.M., Kok R.J., Meijer D.K., Beljaars L., and Poelstra K. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. J. Hepatol. 43 (2005) 884-892
67. Eavarone D.A., Yu X., and Bellamkonda R.V. Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J. Biomed. Mater. Res. 51 (2000) 10-14
68. Dufes C., Muller J.M., Couet W., Olivier J.C., Uchegbu I.F., and Schatzlein A.G. Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles. Pharm. Res. 21 (2004) 101-107
69. Holladay S.R., Yang Z., Kennedy M.D., Leamon C.P., Lee R.J., Jayamani M., Mason T., and Low P.S. Riboflavin-mediated delivery of a macromolecule into cultured human cells. Biochim. Biophys. Acta 1426 (1999) 195-204
70. Mitra A., Nan A., Line B.R., and Ghandehari H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr. Pharm. Des. 12 (2006) 4729-4749
71. Quick G., van Zyl J., Hawtrey A., and Ariatti M. Effect of nicotinic acid conjugated to DNA-transfecting complexes targeted at the transferrin receptor of HeLa cells. Drug Deliv. 7 (2000) 231-236
72. Dalton S.R., Wiegert R.L., and Casey C.A. Receptor-mediated endocytosis by the asialoglycoprotein receptor: effect of ethanol administration on endosomal distribution of receptor and ligand. Liver Int. 23 (2003) 484-491